Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes.
暂无分享,去创建一个
S. Waters | M. Stýblo | Z. Drobnâ | Edward L LeCluyse | David J Thomas | E. LeCluyse | Stephen B Waters | Zuzana Drobná | Felecia S Walton | Miroslav Stýblo | F. Walton | D. Thomas
[1] W B Jakoby,et al. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. , 1974, The Journal of biological chemistry.
[2] P. Agre,et al. Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Anderson,et al. Determination of glutathione and glutathione disulfide in biological samples. , 1985, Methods in enzymology.
[4] M. Lieberman,et al. The MRP2/cMOAT Transporter and Arsenic-Glutathione Complex Formation Are Required for Biliary Excretion of Arsenic* , 2000, The Journal of Biological Chemistry.
[5] M. Delnomdedieu,et al. Transfer of arsenite from glutathione to dithiols: a model of interaction. , 1993, Chemical research in toxicology.
[6] B. Walsh,et al. Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/hGSTO1 gene and changes in urinary arsenic profiles. , 2003, Chemical research in toxicology.
[7] Liang-Shang Gan,et al. Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[8] W. Cullen,et al. Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. , 2001, Chemical research in toxicology.
[9] D. E. Carter,et al. Reactions of arsenic(III) and arsenic(V) species with glutathione. , 1993, Chemical research in toxicology.
[10] J. Buchet,et al. The influence of liver disease on the methylation of arsenite in humans , 1984, Archives of Toxicology.
[11] H. Aebi,et al. Catalase in vitro. , 1984, Methods in enzymology.
[12] E. Silbergeld,et al. Variability in human metabolism of arsenic. , 2003, Environmental research.
[13] S. Waters,et al. Endogenous reductants support the catalytic function of recombinant rat cyt19, an arsenic methyltransferase. , 2004, Chemical research in toxicology.
[14] Z. Gregus,et al. Reduction of arsenate to arsenite in hepatic cytosol. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[15] W. Cullen,et al. Metabolism of arsenic in primary cultures of human and rat hepatocytes. , 1999, Chemical research in toxicology.
[16] M. Stýblo,et al. Binding of arsenicals to proteins in an in vitro methylation system. , 1997, Toxicology and applied pharmacology.
[17] M. Vahter. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. , 2000, Toxicology letters.
[18] M. Stýblo,et al. Comparative in vitro methylation of trivalent and pentavalent arsenicals. , 1995, Toxicology and applied pharmacology.
[19] E L LeCluyse,et al. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[20] Shan Lin,et al. The cellular metabolism and systemic toxicity of arsenic. , 2001, Toxicology and applied pharmacology.
[22] G. Hamilton,et al. Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell-cell interactions , 2001, Cell and Tissue Research.
[23] Y. Berger,et al. Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up , 2000, Xenobiotica; the fate of foreign compounds in biological systems.
[24] Kathy Carroll,et al. Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes , 2000, Journal of biochemical and molecular toxicology.
[25] H. Aposhian,et al. Enzymatic methylation of arsenic compounds. V. Arsenite methyltransferase activity in tissues of mice. , 1998, Toxicology and applied pharmacology.
[26] W. Cullen,et al. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells , 2000, Archives of Toxicology.
[27] Keiko Takahashi,et al. Methylation of arsenic trioxide in hamsters with liver damage induced by long-term administration of carbon tetrachloride , 1988 .
[28] M. Stýblo,et al. In vitro inhibition of glutathione reductase by arsenotriglutathione. , 1995, Biochemical pharmacology.
[29] J. Buchet,et al. Abnormal methylation capacity in human liver cirrhosis. , 1988, International journal of clinical pharmacology research.
[30] Frank Stahl,et al. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[31] H. Aposhian,et al. Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase. , 1999, Chemical research in toxicology.
[32] Z. Gregus,et al. Purine nucleoside phosphorylase as a cytosolic arsenate reductase. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[33] J. B. Simeonsson,et al. A NovelS-Adenosyl-l-methionine:Arsenic(III) Methyltransferase from Rat Liver Cytosol* , 2002, The Journal of Biological Chemistry.
[34] D. Liebler,et al. Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. , 2001, Chemical research in toxicology.
[35] E. Kenyon,et al. Pharmacokinetic Modeling of Arsenite Uptake and Metabolism in Hepatocytes—Mechanistic Insights and Implications for Further Experiments , 2002, Journal of Pharmacokinetics and Pharmacodynamics.
[36] P. Agre,et al. Aquaglyceroporin AQP9: Solute permeation and metabolic control of expression in liver , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] M. Delnomdedieu,et al. Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance study. , 1994, Chemico-biological interactions.
[38] H. Jinno,et al. Functional characterization of two variant human GSTO 1-1s (Ala140Asp and Thr217Asn). , 2003, Biochemical and biophysical research communications.
[39] W. Cullen,et al. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. , 1997, Chemical research in toxicology.
[40] H. Aposhian,et al. Arsenic binding proteins of mammalian systems: I. Isolation of three arsenite-binding proteins of rabbit liver. , 1994, Toxicology.
[41] M. Delnomdedieu,et al. Biological Mechanisms and Toxicological Consequences of the Methylation of Arsenic , 1995 .
[42] W. Cullen,et al. The reaction of methylarsenicals with thiols: Some biological implications , 1984 .
[43] T. Radabaugh,et al. Arsenate reductase II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. , 2002, Chemical research in toxicology.
[44] A. Cornish-Bowden. Fundamentals of Enzyme Kinetics , 1979 .
[45] M. Stýblo,et al. Liberation and analysis of protein-bound arsenicals. , 1996, Journal of chromatography. B, Biomedical applications.
[46] H. Aposhian,et al. Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. , 1995, Chemical research in toxicology.
[47] C. Asher,et al. Preparation and purification of 74As-labeled arsenate and arsenite for use in biological experiments. , 1977, Analytical biochemistry.
[48] S. Waters,et al. Selenium compounds modulate the activity of recombinant rat AsIII-methyltransferase and the methylation of arsenite by rat and human hepatocytes. , 2003, Chemical research in toxicology.